Judge Delays Wind-Down In MDL Over Merck's Fosamax

Law360, Los Angeles (October 04, 2013, 3:59 PM ET) -- A New York federal judge on Thursday delayed the transfer of hundreds of lawsuits in multidistrict litigation over jaw injuries allegedly caused by the bone drug Fosamax in order to give the plaintiffs and Merck & Co. Inc. time to potentially reach a settlement.

Amending his August remand order sending the suits back to their home courts starting Nov. 1, U.S. District Judge John Keenan said the transfers will instead begin Dec. 2. Subsequent transfers will be made on the first business day of every month...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required